Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $202,664.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Robert Desantis also recently made the following trade(s):

• On Friday, October 25th, Robert Desantis sold 1,012 shares of Intuitive Surgical stock. The stock was sold at an average price of $514.00, for a total transaction of $520,168.00.
• On Tuesday, October 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76.
• On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The shares were sold at an average price of $477.50, for a total value of $113,645.00.

Intuitive Surgical Price Performance

ISRG stock traded up $3.45 during trading hours on Monday, reaching $542.00. 718,571 shares of the stock were exchanged, compared to its average volume of 1,452,211. The firm’s 50-day moving average is $510.03 and its 200-day moving average is $469.49. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The company has a market cap of $193.05 billion, a price-to-earnings ratio of 87.14, a PEG ratio of 5.33 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms recently issued reports on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. BTIG Research lifted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. Citigroup increased their target price on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Finally, Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their target price for the stock from $522.00 to $650.00 in a research report on Monday. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $536.61.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ISRG. Massmutual Trust Co. FSB ADV increased its position in shares of Intuitive Surgical by 13.8% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 1,058 shares of the medical equipment provider’s stock worth $471,000 after purchasing an additional 128 shares during the last quarter. City State Bank increased its holdings in Intuitive Surgical by 15.2% during the second quarter. City State Bank now owns 228 shares of the medical equipment provider’s stock worth $101,000 after buying an additional 30 shares during the last quarter. Mather Group LLC. raised its position in Intuitive Surgical by 49.7% during the second quarter. Mather Group LLC. now owns 2,371 shares of the medical equipment provider’s stock worth $1,055,000 after acquiring an additional 787 shares in the last quarter. Fragasso Financial Advisors Inc grew its position in shares of Intuitive Surgical by 12.1% in the 2nd quarter. Fragasso Financial Advisors Inc now owns 613 shares of the medical equipment provider’s stock valued at $273,000 after acquiring an additional 66 shares during the period. Finally, Trust Co. of Vermont grew its position in shares of Intuitive Surgical by 8.8% in the 2nd quarter. Trust Co. of Vermont now owns 5,049 shares of the medical equipment provider’s stock valued at $2,246,000 after acquiring an additional 410 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.